HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Thursday, 21 June 2012

Recent CUAs

Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers.  39 papers were listed this time. Here's a few in our areas of research interest:

Hamers FF, Rumeau-Pichon C. Cost-effectiveness analysis of universal newborn screening for medium chain acyl-CoA dehydrogenase deficiency in France. BMC Pediatr. 2012 Jun 8;12(1):60. [Epub ahead of print] PubMed PMID: 22681855.

Kourlaba G, Fragoulakis V, Maniadakis N. Economic Evaluation of Clopidogrel in Acute Coronary Syndrome Patients without ST-Segment Elevation in Greece: A Cost-Utility Analysis. Appl Health Econ Health Policy. 2012 Jun 5. [Epub ahead of print] PubMed PMID: 22667992.

Mullins CD, Hsiao FY, Onukwugha E, et al. Comparative and cost-effectiveness of oxaliplatin-based or irinotecan-based regimens compared with 5-fluorouracil/leucovorin alone among US elderly stage IV colon cancer patients. Cancer. 2012 Jun 15;118(12):3173-81. Epub 2011 Oct 21. PubMed PMID: 22020739.